Greece vs Mexico: Number of clinical trials

Greece
72 trials
in 2024
Mexico
68 trials
in 2024
Greece rank
30th
Mexico rank
31st

Number of clinical trials over time

  • Greece
  • Mexico
0255075100200020122024

How they compare

Greece currently reports 72 trials against 68 trials in Mexico, a difference of 4 trials.

That makes Greece's figure about 1.1 times Mexico's.

The two have swapped places 9 times across 22 shared years of data; in 2001 it was Mexico ahead.

Greece ranks 30th and Mexico ranks 31st of 153 countries.

Across the 3 decades both report, Greece averaged higher in 1 and Mexico in 2.

Head to head by decade

Decade Greece Mexico Difference Ahead
2000s 13.57 trials 15.43 trials 1.86 trials Mexico
2010s 52 trials 53.8 trials 1.8 trials Mexico
2020s 92 trials 83.4 trials 8.6 trials Greece

Averages of every year both report within each decade.

Frequently asked questions

Which has higher number of clinical trials, Greece or Mexico?
Greece, at 72 trials against 68 trials in Mexico as of 2024.
What is the difference in number of clinical trials between Greece and Mexico?
4 trials, with Greece ahead.
How many years of comparable data are there for Greece and Mexico?
22 years are reported by both, from 2001 to 2024.
How do Greece and Mexico rank globally for number of clinical trials?
Greece ranks 30th and Mexico ranks 31st of 153 countries.
Where does this data come from?
ClinicalTrials.gov (2025) – with major processing by Our World in Data, published as Number of clinical trials. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

About this data

Indicator
Number of clinical trials
Unit
trials
Source
ClinicalTrials.gov (2025) – with major processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
153 places, 2,621 data points, 2000–2024
Last refreshed

Annual number of completed clinical trials registered in the ClinicalTrials.gov database for each country. Registration in the ClinicalTrials database is mandatory for trials in the United States, but voluntary for other countries.